Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Following last week’s announcement of new capital rules by the Federal Reserve, JPMorgan Chase & Co. ( JPM - Analyst Report ) has announced that it will redeem about $9 billion in trust preferred securities (TruPS). As per the new capital proposal, the TruPS issued prior to May 19, 2010 would no longer qualify for Tier 1 capital ratio calculations beginning 2013.
The redemption includes $5.7 billion worth of capital securities related to different series and Fixed-to-Floating Rate Capital Securities worth $3.3 billion. JPMorgan stated that all these securities will be redeemed at 100% of the liquidation amount. The redemption amount will also include accrued and unpaid distributions until the redemption date.
JPMorgan further mentioned that it will use the existing available cash to fund these redemptions. The redemptions will take place on July 12, 2012.
Previously, in March, JPMorgan had announced the redemption of about $425 million in TruPS. These included 17 million of 7.20% preferred securities, issued by BANK ONE Capital VI.
During mid-March, the Federal Reserve informed JPMorgan that its capital deployment plan, submitted under Comprehensive Capital Analysis and Review (CCAR) or the stress test, has been approved. Consequently, the company announced a dividend increase and a new share repurchase authorization. The redemption of TruPS followed this approval.
In May, in its quarterly regulatory filing, JPMorgan stated that its chief investment office (CIO) incurred nearly $2 billion mark-to-market losses during the first six weeks of the current quarter in its synthetic credit portfolio. This portfolio was to protect the company against the potential losses on its large holdings of loans, deposits and bonds.
However, the company’s strategy backfired as the repositioning of the credit portfolio was poorly monitored and executed. Yet, the clearance of the stress test is a testimony of JPMorgan’s solid capital position. With its proven cash generating capacities, the company remains committed to its shareholders by enhancing their wealth through dividend hikes and share buybacks.
Last week, among JPMorgan’s peers- SunTrust Banks Inc. ( STI - Analyst Report ) also stated that it will be redeeming TruPS worth approximately $1.19 billion. The redemption includes SunTrust Capital VIII 6.1% TruPS with maturity date of December 15, 2036 and SunTrust Capital IX 7.875% TruPS maturing on March 15, 2068.
Another peer, Citigroup Inc. ( C - Analyst Report ) , whose extra capital deployment request was rejected by the Fed, announced that it would not request for any additional capital deployment while re-submitting its capital plan to the Fed. Citigroup would continue to pay its current dividend of 1 cent per share. Similar to JPMorgan, Citigroup has also announced the redemption of TruPS.
Redeeming TruPS will enable banks to bring down their interest expenses, as these securities demand higher rates than other securities. Moreover, according to Dodd-Frank Act, banks will no longer be able to consider these securities as regulatory capital from 2013.
JPMorgan currently retains a Zacks #3 Rank, which translates into a short-term ‘Hold’ rating. Considering the fundamentals, we also maintain a long-term Neutral recommendation on the stock.
Read the full reports :
Analyst Report on JPM
Analyst Report on STI
Analyst Report on C